Mineralys Therapeutics Inc (MLYS) USD0.0001
1.26%- This stock can be held in a
Stocks and Shares ISASell:$13.34
Buy:$13.35
Change:
$0.75
(5.32%)
$0.75
(5.32%)Market closed | Prices delayed by at least 15 minutes
Sell:$13.34
Buy:$13.35
Change:$0.75
(5.32%)
$0.75
(5.32%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 14 April 2025 | David Malcom RodmanOther Level A | Sell Option/Award related | 2,966 | $13.69 | $40,613.14 | 120,086 |
| 14 April 2025 | David Malcom RodmanOther Level A | Sell Regular sell transaction (market) | 8,400 | $14.83 | $124,572.00 | 111,686 |
| 11 April 2025 | Jon CongletonCEO | Sell Option/Award related | 15,319 | $12.19 | $186,802.95 | 862,289 |
| 11 April 2025 | Adam Scott LevyCFO | Sell Option/Award related | 10,757 | $12.06 | $129,684.24 | 215,340 |
| 1 April 2025 | David Malcom RodmanOther Level A | Sell Regular sell transaction (market) | 30,574 | $15.00 | $458,542.74 | 141,901 |
| 1 April 2025 | David Malcom RodmanOther Level A | Sell Regular sell transaction (market) | 2,791 | $16.02 | $44,717.12 | 139,110 |
| 1 April 2025 | David Malcom RodmanOther Level A | Sell Regular sell transaction (market) | 22,406 | $16.77 | $375,748.62 | 116,704 |
| 13 March 2025 | SAMSARA BIOCAPITAL GP LLCVenture Capital | Buy Regular purchase transaction | 600,000 | $13.50 | $8,100,000.00 | 5,674,916 |
| 13 March 2025 | RA CAPITAL MANAGEMENT LPInvestment Management Company | Buy Regular purchase transaction | 1,296,296 | $13.50 | $17,499,996.00 | 4,280,051 |
| 13 January 2025 | Jon CongletonCEO | Sell Option/Award related | 18,333 | $9.06 | $166,082.31 | 877,608 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 13 March 2025 | RA CAPITAL MANAGEMENT LPInvestment Management Company | Buy Regular purchase transaction | 1,296,296 | $13.50 | $17,499,996.00 | 4,280,051 |
| 13 March 2025 | SAMSARA BIOCAPITAL GP LLCVenture Capital | Buy Regular purchase transaction | 600,000 | $13.50 | $8,100,000.00 | 5,674,916 |
| 24 July 2024 | CATALYS PACIFIC FUND LPVenture Capital | Sell Regular sell transaction (market) | 550,000 | $13.05 | $7,177,500.00 | 8,644,579 |
| 11 June 2024 | Adam Scott LevyCFO | Sell Option/Award related | 96,815 | $12.94 | $1,252,718.33 | 255,462 |
| 13 June 2024 | Jon CongletonCEO | Sell Option/Award related | 39,961 | $12.74 | $509,027.21 | 992,500 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.